Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure. / Papúchová, Henrieta; Saxtorph, Malene Hviid; Hallager, Trine; Jepsen, Ida E; Eriksen, Jens O; Persson, Gry; Funck, Tina; Weisdorf, Iben; Macklon, Nicholas; Larsen, Lise Grupe; Hviid, Thomas Vauvert F.

In: Reproductive BioMedicine Online, Vol. 47, No. 3, 103225, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Papúchová, H, Saxtorph, MH, Hallager, T, Jepsen, IE, Eriksen, JO, Persson, G, Funck, T, Weisdorf, I, Macklon, N, Larsen, LG & Hviid, TVF 2023, 'Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure', Reproductive BioMedicine Online, vol. 47, no. 3, 103225. https://doi.org/10.1016/j.rbmo.2023.04.016

APA

Papúchová, H., Saxtorph, M. H., Hallager, T., Jepsen, I. E., Eriksen, J. O., Persson, G., Funck, T., Weisdorf, I., Macklon, N., Larsen, L. G., & Hviid, T. V. F. (2023). Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure. Reproductive BioMedicine Online, 47(3), [103225]. https://doi.org/10.1016/j.rbmo.2023.04.016

Vancouver

Papúchová H, Saxtorph MH, Hallager T, Jepsen IE, Eriksen JO, Persson G et al. Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure. Reproductive BioMedicine Online. 2023;47(3). 103225. https://doi.org/10.1016/j.rbmo.2023.04.016

Author

Papúchová, Henrieta ; Saxtorph, Malene Hviid ; Hallager, Trine ; Jepsen, Ida E ; Eriksen, Jens O ; Persson, Gry ; Funck, Tina ; Weisdorf, Iben ; Macklon, Nicholas ; Larsen, Lise Grupe ; Hviid, Thomas Vauvert F. / Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure. In: Reproductive BioMedicine Online. 2023 ; Vol. 47, No. 3.

Bibtex

@article{6c1159f3d11d44198c0e8475cec35a2e,
title = "Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure",
abstract = "RESEARCH QUESTION: The human leukocyte antigen (HLA) class Ib molecules HLA-F and HLA-G are implicated in pregnancy success, but how do HLA-G and HLA-F genetic polymorphisms impact recurrent implantation failure (RIF)?DESIGN: Prospective cohort study at a fertility clinic including a cohort of 84 women experiencing RIF and 35 IVF controls to assess the influence of HLA-G haplotypes and diplotypes and HLA-F single nucleotide polymorphisms (SNP) on RIF.RESULTS: Over-representation trends for HLA-F SNP genotypes rs1362126, rs2523405 and rs2523393, previously linked with a short time-to-pregnancy, were detected in female control groups compared with RIF patients with no identified pathology linked to infertility. The HLA-G promoter haplotype PROMO-G010101b/c linked with the HLA-G 3'-untranslated region (3'UTR) haplotype UTR-4, which previously has been associated with positive IVF outcome and pregnancy success, was less frequent in the RIF group. For RIF patients carrying the UTR-4 haplotype, the odds ratio (OR) was 0.27 (95% CI 0.12-0.66; P = 0.0044, P c = 0.026). The HLA-G PROMO-G010104-UTR-3 haplotype was associated with an increased risk of RIF. For RIF patients carrying the UTR-3 haplotype, the OR was 5.86 (95% CI 1.52-26.23; P = 0.0115, P c = 0.069). CONCLUSIONS: These results show that specific HLA-G haplotypes based on the promoter region and the 3'UTR are either associated with an increased risk of reduced fertility, including the manifestation of RIF, and lower chance of achieving pregnancy, or with a reduced risk of experiencing RIF.",
author = "Henrieta Pap{\'u}chov{\'a} and Saxtorph, {Malene Hviid} and Trine Hallager and Jepsen, {Ida E} and Eriksen, {Jens O} and Gry Persson and Tina Funck and Iben Weisdorf and Nicholas Macklon and Larsen, {Lise Grupe} and Hviid, {Thomas Vauvert F}",
note = "Copyright {\textcopyright} 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.",
year = "2023",
doi = "10.1016/j.rbmo.2023.04.016",
language = "English",
volume = "47",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - Opposing impacts of HLA-G haplotypes PROMO-G010104-UTR-3 and PROMO-G010101b/c-UTR-4 on risk of recurrent implantation failure

AU - Papúchová, Henrieta

AU - Saxtorph, Malene Hviid

AU - Hallager, Trine

AU - Jepsen, Ida E

AU - Eriksen, Jens O

AU - Persson, Gry

AU - Funck, Tina

AU - Weisdorf, Iben

AU - Macklon, Nicholas

AU - Larsen, Lise Grupe

AU - Hviid, Thomas Vauvert F

N1 - Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

PY - 2023

Y1 - 2023

N2 - RESEARCH QUESTION: The human leukocyte antigen (HLA) class Ib molecules HLA-F and HLA-G are implicated in pregnancy success, but how do HLA-G and HLA-F genetic polymorphisms impact recurrent implantation failure (RIF)?DESIGN: Prospective cohort study at a fertility clinic including a cohort of 84 women experiencing RIF and 35 IVF controls to assess the influence of HLA-G haplotypes and diplotypes and HLA-F single nucleotide polymorphisms (SNP) on RIF.RESULTS: Over-representation trends for HLA-F SNP genotypes rs1362126, rs2523405 and rs2523393, previously linked with a short time-to-pregnancy, were detected in female control groups compared with RIF patients with no identified pathology linked to infertility. The HLA-G promoter haplotype PROMO-G010101b/c linked with the HLA-G 3'-untranslated region (3'UTR) haplotype UTR-4, which previously has been associated with positive IVF outcome and pregnancy success, was less frequent in the RIF group. For RIF patients carrying the UTR-4 haplotype, the odds ratio (OR) was 0.27 (95% CI 0.12-0.66; P = 0.0044, P c = 0.026). The HLA-G PROMO-G010104-UTR-3 haplotype was associated with an increased risk of RIF. For RIF patients carrying the UTR-3 haplotype, the OR was 5.86 (95% CI 1.52-26.23; P = 0.0115, P c = 0.069). CONCLUSIONS: These results show that specific HLA-G haplotypes based on the promoter region and the 3'UTR are either associated with an increased risk of reduced fertility, including the manifestation of RIF, and lower chance of achieving pregnancy, or with a reduced risk of experiencing RIF.

AB - RESEARCH QUESTION: The human leukocyte antigen (HLA) class Ib molecules HLA-F and HLA-G are implicated in pregnancy success, but how do HLA-G and HLA-F genetic polymorphisms impact recurrent implantation failure (RIF)?DESIGN: Prospective cohort study at a fertility clinic including a cohort of 84 women experiencing RIF and 35 IVF controls to assess the influence of HLA-G haplotypes and diplotypes and HLA-F single nucleotide polymorphisms (SNP) on RIF.RESULTS: Over-representation trends for HLA-F SNP genotypes rs1362126, rs2523405 and rs2523393, previously linked with a short time-to-pregnancy, were detected in female control groups compared with RIF patients with no identified pathology linked to infertility. The HLA-G promoter haplotype PROMO-G010101b/c linked with the HLA-G 3'-untranslated region (3'UTR) haplotype UTR-4, which previously has been associated with positive IVF outcome and pregnancy success, was less frequent in the RIF group. For RIF patients carrying the UTR-4 haplotype, the odds ratio (OR) was 0.27 (95% CI 0.12-0.66; P = 0.0044, P c = 0.026). The HLA-G PROMO-G010104-UTR-3 haplotype was associated with an increased risk of RIF. For RIF patients carrying the UTR-3 haplotype, the OR was 5.86 (95% CI 1.52-26.23; P = 0.0115, P c = 0.069). CONCLUSIONS: These results show that specific HLA-G haplotypes based on the promoter region and the 3'UTR are either associated with an increased risk of reduced fertility, including the manifestation of RIF, and lower chance of achieving pregnancy, or with a reduced risk of experiencing RIF.

U2 - 10.1016/j.rbmo.2023.04.016

DO - 10.1016/j.rbmo.2023.04.016

M3 - Journal article

C2 - 37330336

VL - 47

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 3

M1 - 103225

ER -

ID: 357092968